Cookies on the BTG website

We use cookies to ensure that we give you the best experience on our website.

If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the BTG website.

Find out more

About Us

Email to a friend
Email to a friend

* Required

Who We Are

We are a growing international specialist healthcare company. Our mission is to bring to market medical products that meet the needs of specialist healthcare physicians and their patients.

We are focused on three business areas: Interventional Medicine, Specialty Pharmaceuticals and Licensing.

Our Interventional Medicines include Interventional Oncology products used to treat patients with liver tumours and Interventional Vascular products used to treat patients with severe blood clots and patients with varicose veins in the great saphenous vein system of the leg.

Our Specialty Pharmaceutical products include antidotes to treat snake envenomation and toxicity associated with medicines used for heart conditions and cancer.

We develop our own products and in-license or acquire them from others. We sell direct to our customers in the US and elsewhere principally through distribution partners.

In everything we do, we are guided by our core values and our Code of Conduct. We believe that by doing the right thing we will deliver enduring value to all our stakeholders.


BTG at a glance

Our latest Corporate Profile provides a snapshot of us today.

Corporate Profile Thumbnail image Year End Results 21 May 2012Corporate Profile
Download document (PDF - 110KB) 

Developing innovative new products

We plan to take our development programmes to market ourselves.

Our culture
our culture

Find out about how we’re building a collaborative spirit, based on mutual respect, where employees have a clear sense of purpose.